a review of interventions to reduce polypharmacy in the
Post on 23-May-2022
1 Views
Preview:
TRANSCRIPT
Faculty Disclosure Monte SV discloses ownership in Mobile Pharmacy Solutions.
A Review of Interventions to Reduce Polypharmacy in the Elderly: Lost in Translation?Baumgartner A , Verni C, LaValley S, Wahler RG, Monte SV, Singh R.
Statement of Problem
Materials and Methods
Design: Narrative review of high quality studies of medication safety interventions with older adults.Sources: Relevant abstracts in PubMed dated between 2000 and 2017 using MESH headings, “Drug-related side effects AND Adverse Reactions AND Aged AND Intervention.” Inclusion Criteria:• RCT or prospective cohort study design• Medication Safety Intervention• Involved the elderly in their study population• Measured ED visits and/or hospitalization rates as
outcome measures• Had completed resultsExclusion Criteria:• Limited to a single disease conditionAnalysis:• Included articles were analyzed for discussion of
factors relevant to implementation, as defined by the Consolidated Framework for Implementation Research (CFIR)
• Each implementation factor, and their assigned CFIR domain, was independently identified by 2 reviewers and disagreements were resolved by discussion
• Process measures and intermediate outcomes were also identified
Results
Conclusion
References
www.buffalo.edu
Objective
PRISMA Chart
Future Implications
• To assess the extent to which the literature
described and explored factors relevant to
successful intervention implementation. Study findings:• Study settings included hospital (n=4), skilled nursing (n=2), and outpatient (n=4)• Intervention types included medication review (n=7), and clinical decision support (n=2)• 1/10 MSIs improved ED visits and/or hospitalization rates (after post-hoc analysis)
Attention to implementation process:• 6/10 papers discussed implementation factors that could be identified in the CFIR but
very few of the potential factors in CFIR were touched upon (see Chart)• 8/10 studies presented process measures / intermediate outcomes but this was done in
an inconsistent way (see Table)
• Potentially inappropriate prescribing represents a significant risk to patients, including emergency department visits and hospitalizations
• Evidenced based criteria, such as the Beers and START/STOP criteria, have had difficulty being implemented into everyday practice
• Medication safety interventions (MSIs) designed to implement these practices have had inconsistent results, particularly when measuring emergency department visits and hospitalizations as the primary outcome
Author Process measure / intermediate
outcome
Pt
char
acte
rist
ics
asso
ciat
ed
wit
h D
RP
s
Nu
mb
er
or
rate
of
DR
Ps
Typ
es
of
dru
gs a
sso
ciat
ed
wit
h D
rug
rela
ted
pro
ble
ms
(DR
Ps)
Typ
es
of
reco
mm
en
dat
ion
s
mad
e
Tim
e s
pe
nt
by
ph
arm
acis
t
Rat
e o
f P
resc
rib
er
acce
pta
nce
of
reco
mm
en
dat
ion
s
Mannheimer X X X
Surgery and
Pharmacy in
Liaison Study
Group
X X X
Kjeldsen
Marusic X
Lapane XLenander X XLeenderstse X X
Touchette XDonovan
Farris X X
CFIR Constructs and Factors Identified
Intervention Characteristics:Evidence Strength and Quality: (1) • Intervention limited to 5 high risk meds
Outer Setting:Patient Needs and Resources: (2)• ADE rate in surgical patients• Pre-intervention med adherence
Inner Setting:Networks and Communication (6)• Pharmacist integration **• Patient-Pharmacist relationshipAvailable Resources (1)• Logistical strain on the pharmacist• Time per patient
Process:Reflecting and Evaluating: (2)• Evaluation of intervention process limitations• Impact of inclusion criteria
Characteristics of IndividualsOther Personal Attributes: (1)• Pharmacist educational background
• Translational gap: Our review of high quality MSI studies confirms that evidenced based practices have difficulty being translated into the clinical setting
• Unclear impact of MSIs: Most studies failed to show an impact on hospitalizations and ED visits
• Process of implementation not adequately addressed: Therefore, a possible explanation for the lack of clear impact of MSIs the outcomes measured is that their effect was lost in translation.
1. Budnitz, D.S., et al., Emergency Hospitalizations for Adverse Drug Events in Older Americans. New England Journal of Medicine, 2011. 365(21): p. 2002-2012.2. Gallagher, P., et al., STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther, 2008. 46(2): p. 72-83.3. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.J Am Geriatr Soc, 2015. 63(11): p. 2227-46.4. Onder, G., et al., Strategies to reduce the risk of iatrogenic illness in complex older adults. Age Ageing, 2013. 42(3): p. 284-91.5. Ovretveit, J.C., et al., How does context affect interventions to improve patient safety? An assessment of evidence from studies of five patient safety practices and proposals for research. BMJ Qual Saf, 2011. 20(7): p. 604-10.6. Damschroder, L.J., et al., Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci, 2009. 4: p. 50.7. Leendertse, A.J., et al., Preventing hospital admissions by reviewing medication (PHARM) in primary care: an open controlled study in an elderly population. J Clin Pharm Ther, 2013. 38(5): p. 379-87.8. Kjeldsen, L.J., et al., Evaluation of a controlled, national collaboration study on a clinical pharmacy service of screening for risk medications. Int J Clin Pharm, 2014. 36(2): p. 368-76.9. Farris, K.B., et al., Effect of a care transition intervention by pharmacists: an RCT. BMC Health Serv Res, 2014. 14: p. 406.10. Damschroder, L. J., Aron, D. C., Keith, R. E., Kirsh, S. R., Alexander, J. A., & Lowery, J. C. (2009). Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science. Implementation Science, 4(1). doi:10.1186/1748-5908-4-50
KEY:
CFIR Construct Category:CFIR Construct (# of mentions) • Specific factor identified in the
literature
• A systematic approach: Studies should be designed with appreciation for the role of the implementation process. This may provide more fruitful analysis as well as providing benchmark process measures for future comparison.
• Multi-pronged analysis: A combination of patient outcomes, process outcomes, and qualitative analysis can be used synergistically to fully evaluate the implementation process
• CFIR as a tool: CFIR can be applied to medication safety interventions to accomplish these goals.
Records identified (PubMed)(n = 387)
Records screened(n = 387)
Records Excluded(n = 351)
Full-text articles assessed for eligibility(n = 36)
Full-text articles excluded(n = 26)
Studies included in qualitative synthesis(n = 10)
top related